PL365314A1 - Sekwencje powyżej genu CARP, wektory zawierające te sekwencje i ich zastosowanie - Google Patents

Sekwencje powyżej genu CARP, wektory zawierające te sekwencje i ich zastosowanie

Info

Publication number
PL365314A1
PL365314A1 PL01365314A PL36531401A PL365314A1 PL 365314 A1 PL365314 A1 PL 365314A1 PL 01365314 A PL01365314 A PL 01365314A PL 36531401 A PL36531401 A PL 36531401A PL 365314 A1 PL365314 A1 PL 365314A1
Authority
PL
Poland
Prior art keywords
sequences
vectors containing
upstream
carp gene
carp
Prior art date
Application number
PL01365314A
Other languages
English (en)
Inventor
Patrick Benoit
Bertrand Schwartz
Didier Branellec
Kenneth Chien
Ju Chen
Original Assignee
Gencell S.A.
The Regents Of The University Of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gencell S.A., The Regents Of The University Of California filed Critical Gencell S.A.
Publication of PL365314A1 publication Critical patent/PL365314A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/008—Vector systems having a special element relevant for transcription cell type or tissue specific enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/15—Vector systems having a special element relevant for transcription chimeric enhancer/promoter combination
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/60—Vector systems having a special element relevant for transcription from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2830/00—Vector systems having a special element relevant for transcription
    • C12N2830/80—Vector systems having a special element relevant for transcription from vertebrates
    • C12N2830/85—Vector systems having a special element relevant for transcription from vertebrates mammalian

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PL01365314A 2000-12-07 2001-12-05 Sekwencje powyżej genu CARP, wektory zawierające te sekwencje i ich zastosowanie PL365314A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25158200P 2000-12-07 2000-12-07

Publications (1)

Publication Number Publication Date
PL365314A1 true PL365314A1 (pl) 2004-12-27

Family

ID=22952571

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01365314A PL365314A1 (pl) 2000-12-07 2001-12-05 Sekwencje powyżej genu CARP, wektory zawierające te sekwencje i ich zastosowanie

Country Status (18)

Country Link
US (3) US7193075B2 (pl)
EP (1) EP1358208A2 (pl)
JP (1) JP2004519222A (pl)
KR (1) KR20030090609A (pl)
CN (1) CN1483040A (pl)
AU (2) AU2640002A (pl)
BR (1) BR0116014A (pl)
CA (1) CA2431193A1 (pl)
CZ (1) CZ20031569A3 (pl)
FI (1) FI20030851A7 (pl)
IL (1) IL156137A0 (pl)
MX (1) MXPA03005039A (pl)
NO (1) NO20032584L (pl)
NZ (1) NZ526408A (pl)
PL (1) PL365314A1 (pl)
RU (1) RU2283865C2 (pl)
WO (1) WO2002046220A2 (pl)
ZA (1) ZA200305184B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1677831A1 (en) * 2003-06-05 2006-07-12 Gencell S.A. Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects
MX2010003371A (es) * 2007-09-28 2010-05-05 Intrexon Corp Constructos interruptores genicos terapeuticos y biorreactores para la expresion de moleculas bioterapeuticas y usos de los mismos.
US8257956B2 (en) * 2008-10-28 2012-09-04 E. I. Du Pont De Nemours And Company Sulfonylurea-responsive repressor proteins
RU2515926C2 (ru) * 2009-02-04 2014-05-20 Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем Двойное нацеливание нп mir-208 и mir 499 в лечении заболеваний сердца
RU2497529C2 (ru) * 2011-11-08 2013-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ) Способ стимуляции регенеративных процессов в ишемизированных тканях
CN105779457B (zh) * 2016-05-31 2019-02-12 北京大学 心肌细胞特异启动子及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5819599A (en) * 1998-09-11 2000-04-03 Regents Of The University Of California, The Recombinant adenovirus for tissue specific expression in heart
US6033642A (en) * 1999-03-29 2000-03-07 Starmet Corporation Method for producing silicon tetrafluoride from uranium oxyfluoride

Also Published As

Publication number Publication date
US20030039984A1 (en) 2003-02-27
CN1483040A (zh) 2004-03-17
RU2003120081A (ru) 2005-01-27
ZA200305184B (en) 2004-10-04
NO20032584L (no) 2003-08-05
CA2431193A1 (en) 2002-06-13
FI20030851A7 (fi) 2003-06-06
AU2002226400B2 (en) 2006-11-02
WO2002046220A3 (en) 2003-09-04
JP2004519222A (ja) 2004-07-02
AU2640002A (en) 2002-06-18
WO2002046220A9 (en) 2007-11-08
IL156137A0 (en) 2003-12-23
BR0116014A (pt) 2003-10-21
US7193075B2 (en) 2007-03-20
MXPA03005039A (es) 2004-08-02
NO20032584D0 (no) 2003-06-06
CZ20031569A3 (cs) 2003-11-12
NZ526408A (en) 2005-07-29
EP1358208A2 (en) 2003-11-05
US20070150971A1 (en) 2007-06-28
KR20030090609A (ko) 2003-11-28
WO2002046220A2 (en) 2002-06-13
RU2283865C2 (ru) 2006-09-20
US20060110362A1 (en) 2006-05-25

Similar Documents

Publication Publication Date Title
ID30590A (id) Celana sekali pakai jenis-celana pendek
FI20000852L (fi) Palvelun käytön estäminen tietoliikennejärjestelmässä
EP1418940A4 (en) DNA EXPRESSION VECTORS AND METHODS OF USE
DE60120053D1 (de) Schnalle
FR2818646B1 (fr) Nouveaux derives c-glycoside et utilisation
FI20011664A0 (fi) Syöpäpesifiset oligoskkaridisekvenssit ja niiden käyttö
FI20011671L (fi) Tuumorispesifiset oligosakkaridisekvenssit ja niiden käyttö
DE60113003D1 (de) Schnalle
PL365314A1 (pl) Sekwencje powyżej genu CARP, wektory zawierające te sekwencje i ich zastosowanie
NO20024458D0 (no) Anvendelse av MIA i immunoterapi
AU8229901A (en) Genes and proteins, and their uses
AU9227301A (en) Novel proteins, genes encoding them and method of using the same
HUP0101911A3 (en) Novel sequence class of genes, corresponding proteins and the use of the same
GB0026351D0 (en) Nucleotide sequences and uses thereof
GB0026350D0 (en) Nucleotide sequences and uses thereof
GB0123170D0 (en) Genes,proteins,and their use
GB0003729D0 (en) Virulene gene and protein, and their use
FI4772U1 (fi) Solki
GB0126523D0 (en) Virulence genes, proteins, and their use
SE0100097D0 (sv) Tissue specific genes and their promotors - cell division
NO20004259A (no) Smykkelås
SE0102061D0 (sv) New proteins and the corresponding DNA sequences
TW484374U (en) Structure of hair clasp
FIU990352U0 (fi) Vaatekappaleen solki
AT4051U3 (de) Schmuckstück

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)